Insider Transactions in Q2 2019 at Bicycle Therapeutics PLC (BCYC)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 28
2019
|
Tybourne Capital Management (Hk) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
364,286
+15.69%
|
$5,100,004
$14.0 P/Share
|
|
May 28
2019
|
Tybourne Capital Management (Hk) LTD > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
139,264
+8.04%
|
-
|
|
May 28
2019
|
Tybourne Capital Management (Hk) LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,454,411
+50.0%
|
-
|
|
May 28
2019
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
385,714
+16.76%
|
$5,399,996
$14.0 P/Share
|
|
May 28
2019
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,529,561
+39.69%
|
-
|
|
May 28
2019
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
168,630
+8.7%
|
$2,360,820
$14.0 P/Share
|
|
May 28
2019
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,529,561
+39.22%
|
-
|
|
May 28
2019
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
71,450
+6.9%
|
-
|